We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Congress last week allocated $25 billion to expand access to COVID-19 diagnostic tests as the FDA continues to pull out all the stops to get tests to the marketplace via Emergency Use Authorizations (EUAs) that exempt devicemakers from liability for product failures. Read More
The test uses a drop of blood to detect COVID-19 antibodies in approximately 10 minutes. It can detect both the presence of the virus and a patient’s potential antibody immunity to it. Read More
“Right now, we have no evidence that the use of a serologic test can show that an individual is immune or protected from reinfection,” the WHO official said. Read More
The FDA issued a final rule banning electrical stimulation devices (ESDs) used to reduce aggressive or self-harming behavior, saying that better treatment options are now available. Read More